In an approach that has not yet been tested against RSV infection, the researchers engineered a special type of antibody that ...

Highlights Revenue Milestones and Expands Alternative Protein & Pharmaceutical Partnerships with Dapibus™ & C1 Technology Platforms ...

Moderna has received Health Canada's approval for its respiratory syncytial virus messenger ribonucleic acid (mRNA) vaccine ...

mRESVIA is the only RSV vaccine available in a pre-filled syringe ... the surface of the virus and is required for infection by helping the virus to enter host cells. The prefusion conformation of the ...

Moderna Inc.'s stock was higher but off its early highs Thursday, after the company's third-quarter earnings showed an unexpected profit as well as revenue that beat estimates by a wide margin. The ...

While Moderna’s Spikevax beat Wall Street estimates in the third quarter, William Blair analyst Myles Minter in a Thursday ...

What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...

GlaxoSmithKline (GSK) has received approval for its vaccine, AREXVY, in Canada to prevent lower respiratory tract disease ...

Investigators seized drugs, homemade weapons and electronic devices this week during an “interagency operation” aimed at ...

But which ones should you get? This year marks the second season for the new respiratory syncytial virus vaccine (RSV) for grown-ups. While not everyone needs it, the evidence so far suggests that ...

The North Bay Parry Sound District Health Unit announced the availability of a new preventive medication for Respiratory Syncytial Virus for newborns and eligible infants up to 24 months of age. The ...